Welcome to the international HTA database

Showing [16734 Records] Selected Records [0 Hits] [Clear]

Year	Source	Title
2013	Health Quality Ontario (HQO)	Discharge planning in chronic conditions: an evidence-based analysis
2013	Institute for Clinical Evaluative Sciences (ICES)	Ontario stroke evaluation report 2013: spotlight on secondary stroke prevention and care
2013	Health Quality Ontario (HQO)	In-home care for optimizing chronic disease management in the community: an evidence-based analysis
2013	Institute for Clinical Evaluative Sciences (ICES)	Atlas on the primary care of adults with developmental disabilities in Ontario
2013	Health Quality Ontario (HQO)	Continuity of care to optimize chronic disease management in the community setting: an evidence-based analysis
2013	Health Quality Ontario (HQO)	Impact of advanced (open) access scheduling on patients with chronic diseases: an evidence-based analysis
2013	The Regional Health Technology Assessment Centre (HTA-centrum)	Renal sympathetic denervation in patients with therapy resistant hypertension
2013	Health Quality Ontario (HQO)	Screening and management of depression for adults with chronic diseases: an evidence-based analysis
2013	Health Quality Ontario (HQO)	Self-management support interventions for persons with chronic disease: an evidence-based analysis
2013	Health Quality Ontario (HQO)	Specialized nursing practice for chronic disease management in the primary-care setting: an evidence-based analysis
2013	NIHR Health Technology Assessment programme	Ivabradine for the treatment of chronic heart failure
2013	Health Information and Quality Authority (HIQA)	Health technology assessment (HTA) of surveillance of women aged less than 50 years at elevated risk of breast cancer
2013	Health Quality Ontario (HQO)	Electronic tools for health information exchange: an evidence-based analysis
2013	NIHR Health Technology Assessment programme	Fluocinolone acetonide intravitreal implant for the treatment of chronic diabetic macular oedema
2013	Health Quality Ontario (HQO)	Health technologies for the improvement of chronic disease management: a review of the Medical Advisory Secretariat evidence-based analyses between 2006 and 2011
2013	Medical Advisory Secretariat (MAS)	Transcatheter Aortic Valve Implantation (TAVI) for treatment of aortic valve stenosis: an evidence update
2013	Health Quality Ontario (HQO)	Optimizing chronic disease management mega-analysis: economic evaluation
2013	Health Quality Ontario (HQO)	How diet challenges are magnified in vulnerable or marginalized people with diabetes and heart disease: a systematic review and qualitative meta-synthesis
2013	Health Quality Ontario (HQO)	Chronic disease patients' experiences with accessing health care in rural and remote areas: a systematic review and qualitative meta-synthesis
2013	Health Quality Ontario (HQO)	Patient experiences of depression and anxiety with chronic disease: a systematic review and qualitative meta-synthesis
2013	Agenzia nazionale per i servizi sanitari regionali (Agenas)	Selective Internal Radiation Therapy (SIRT) in colorectal liver metastases
2013	Health Quality Ontario (HQO)	Experiences of patient-centredness with specialized community-based care: a systematic review and qualitative meta-synthesis
2013	Health Quality Ontario (HQO)	Electrical stimulation for drug-resistant epilepsy: an evidence-based analysis
2013	Health Quality Ontario (HQO)	Electrical stimulation for drug-resistant epilepsy: OHTAC recommendation
2013	Health Quality Ontario (HQO)	Carbon-13 urea breath test for Helicobacter pylori infection in patients with uninvestigated ulcer-like dyspepsia: an evidence-based analysis
2013	Health Quality Ontario (HQO)	Carbon-13 urea breath test for Helicobacter pylori infection in patients with uninvestigated ulcer-like dyspepsia: OHTAC recommendation
2013	Health Technology and Policy Unit (HTPU)	Level I and level III sleep studies for the diagnosis of sleep disordered breathing (SDB) in adults
2013	Health Quality Ontario (HQO)	Cost-effectiveness of the carbon-13 urea breath test for the detection of Helicobacter pylori: an economic analysis
2013	Medical Services Advisory Committee (MSAC)	Testing for epidermal growth factor receptor (EGFR) status in patients with locally advanced (stage IIIB) or metastatic (stage IV) non-small cell lung cancer (NSCLC) for access to erlotinib
2013	Health Quality Ontario (HQO)	Hysteroscopic tubal sterilization: an evidence-based analysis
2013	Health Quality Ontario (HQO)	Hysteroscopic tubal sterilization: OHTAC recommendation
2013	Health Quality Ontario (HQO)	Hysteroscopic tubal sterilization: a health economic literature review
2013	Health Quality Ontario (HQO)	Vitamin B12 and cognitive function: an evidence-based analysis
2013	Health Quality Ontario (HQO)	Vitamin B12 and cognitive function: OHTAC recommendation
2013	Health Quality Ontario (HQO)	Vitamin B12 intramuscular injections versus oral supplements: a budget impact analysis
2013	HAYES, Inc.	SensiGene fetal RHD genotyping
2013	University of York	Inpatient rehabilitation services for the frail elderly
2013	Agency for Healthcare Research and Quality (AHRQ)	Pulmonary arterial hypertension: screening, management, and treatment
2013	Health Quality Ontario (HQO)	Deep brain stimulation for treatment-resistant depression: a preliminary evidence review
2013	University of York	Evidence briefing on non-pharmacological interventions for dementia in care home settings
2013	Institute for Clinical and Economic Review (ICER)	Cardiac nuclear imaging
2013	Health Quality Ontario (HQO)	OHTAC recommendation: deep brain stimulation for treatment-resistant depression
2013	University of York	Telehealth for patients with long term conditions
2013	Institute for Clinical and Economic Review (ICER)	Cervical spinal fusion for degenerative disc disease
2013	Health Quality Ontario (HQO)	OHTAC recommendation: endovascular ablation for varicose veins
2013	NIHR Horizon Scanning Centre (NIHR HSC)	The SurroSense Rx™ System for prevention of diabetic foot ulcers
2013	University of York	Evidence briefing on urgent care systems
2013	Health Quality Ontario (HQO)	Appropriateness phase 1 OHTAC recommendations: annual health exams, aspartate aminotransferase testing, chloride testing, creatine kinase testing, ferritin testing, folate testing, and vitamin B12 testing
2013	NIHR Horizon Scanning Centre (NIHR HSC)	ATI™ Neurostimulation System for cluster headache
2013	University of York	Consolidating urgent care services
2013	Health Quality Ontario (HQO)	OHTAC recommendation: midurethral slings for women with stress urinary incontinence
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Ellex 2RT™ for early age-related macular degeneration
2013	University of York	Advance care planning
2013	Agency for Healthcare Research and Quality (AHRQ)	Vitamin, mineral, and multivitamin supplements for the primary prevention of cardiovascular disease and cancer
2013	NIHR Horizon Scanning Centre (NIHR HSC)	OssDsign™ Cranio PSI for skull repair
2013	University of York	Primary care 'in-reach' in hospital settings
2013	Agency for Healthcare Research and Quality (AHRQ)	Screening for cognitive impairment in older adults: an evidence update for the U.S. Preventive Services Task Force.
2013	NIHR Horizon Scanning Centre (NIHR HSC)	SmartSensor electronic oral glucose tolerance test for screening for diabetes
2013	Medical Services Advisory Committee (MSAC)	Testing for V600 status in patients with locally advanced or metastatic melanoma for access to appropriate therapies
2013	Agency for Healthcare Research and Quality (AHRQ)	Screening for lung cancer: systematic review to update the U.S. Preventive Services Task Force Recommendation
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Smart-Glasses depth-based visual aids for the partially sighted
2013	Medical Services Advisory Committee (MSAC)	Cell enrichment liquid based cytology (LBC) in routine screening for the prevention of cervical cancer
2013	NIHR Horizon Scanning Centre (NIHR HSC)	Full Sense™ device for obesity
2013	Medical Services Advisory Committee (MSAC)	Transcatheter closure of patent ductus arteriosus
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Screening tools to identify adults with mild cognitive impairment not associated with dementia: a review of diagnostic accuracy, effectiveness and guidelines
2013	Medical Services Advisory Committee (MSAC)	Epidermal Growth Factor Receptor (EGFR) testing to determine eligibility for afatinib treatment in patients with locally advanced or metastatic non-small-cell lung cancer.
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Mini C-arm imagers for the follow-up of orthopedic patients: clinical effectiveness
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Dressings and care of skin graft sites: a review of clinical evidence and guidelines
2013	Medical Services Advisory Committee (MSAC)	Matrix-induced autologous chondrocyte implant
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Drugs for rare diseases: evolving trends in regulatory and health technology assessment perspectives
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Optimal care of chronic, non-healing, lower extremity wounds: a review of clinical evidence and guidelines
2013	Medical Services Advisory Committee (MSAC)	Sexual health medicine consultation items
2013	Adelaide Health Technology Assessment (AHTA)	Australian guidelines for the treatment of acute stress disorder and posttraumatic stress disorder
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Copper intra-uterine devices as a contraceptive for adult women: a review of clinical effectiveness and safety
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Naloxone for use in long-term care and palliative care: clinical effectiveness, safety, and guidelines
2013	Medical Services Advisory Committee (MSAC)	Addiction medicine consultation items
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Side rails on beds in long-term and residential care facilities: safety and evidence based guidelines
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Interventions for the prevention or management of childhood obesity: a review of the clinical evidence
2013	Medical Services Advisory Committee (MSAC)	Genetic testing for hereditary mutations in the RET gene
2013	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Pomalidomide (Pomalyst®) for the treatment of refractory multiple myeloma or relapsed and refractory multiple myeloma
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Photo-activated disinfection therapy for dental surgery: review of the clinical effectiveness
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Transobturator slings for urinary incontinence: clinical effectiveness and guidelines
2013	Medical Services Advisory Committee (MSAC)	Implantation of fiducial markers into the prostate gland or prostate surgical bed for external beam radiotherapy
2013	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Regorafenib (Stivarga®) in pts with metastatic colorectal cancer (CRC) who have progressed after standard therapy
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Antipsychotics for the management of agitation in adults with personality disorders or cognitive impairment: a review of the clinical effectiveness and guidelines
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Removal of physical restraints in long term care settings: clinical safety and harm
2013	Medical Services Advisory Committee (MSAC)	Gene expression profiling of 21 genes in breast cancer to quantify the risk of disease recurrence and predict adjuvant chemotherapy benefit
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Heating standards for clinical interventions: clinical evidence
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Computed tomography angiography versus computed tomography for the diagnosis and management of hyperacute stroke: a review of comparative clinical evidence and guidelines
2013	Medical Services Advisory Committee (MSAC)	Codependent with PBAC- intravesical injection of botulinum toxin (Botox) into the bladder wall for urinary incontinence due to idiopathic overactive bladder
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Transcendental meditation for posttraumatic stress disorder, depression, and anxiety: a review of clinical effectiveness
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Bioabsorbable stents for adults with coronary artery disease: a review of the clinical effectiveness, cost-effectiveness, and guidelines
2013	Medical Services Advisory Committee (MSAC)	Diagnostic fluorescence in situ hybridisation (FISH) testing for Anaplastic Lymphoma Kinase (ALK) in advanced non-small cell lung cancer (NSCLC) to determine eligibility for crizotinib treatment (co-dependent)
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	GreenLight laser for the treatment of benign prostatic hypertrophy: a review of clinical and cost-effectiveness, and safety
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Diabetes screening for asymptomatic adults: a review of the diagnostic accuracy, cost effectiveness, and guidelines
2013	Medical Services Advisory Committee (MSAC)	Insertion, replacement, or removal of a cardiac resynchronisation therapy device capable of defibrillation (CRT-D) for mild, moderate or severe chronic heart failure (NYHA II, III or IV)
2013	Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA)	Dabrafenib (Tafinlar®) in previously untreated subjects with BRAF mutation-positive advanced (stage III) or metastatic (stage IV) melanoma
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Management of congestive heart failure in primary and community care: guidelines
2013	Canadian Agency for Drugs and Technologies in Health (CADTH)	Fluconazole administration for the treatment of ductal yeast enfections: clinical effectiveness and safety
2013	Medical Services Advisory Committee (MSAC)	Single balloon enteroscopy